Heudel Pierre Etienne, Cousin Philippe, Lurkin Antoine, Cropet Claire, Ducimetiere Françoise, Collard Olivier, De Laroche Guy, Biron Pierre, Meeus Pierre, Thiesse Philippe, Bergeron Christophe, Vaz Gualter, Mithieux François, Farsi Fadila, Fayet Yohan, Gilly François-Noel, Cellier Dominic, Blay Jean-Yves, Ray-Coquard Isabelle
Centre Léon Bérard, 28 Rue Laennec, 69008, Lyon, France,
Int J Clin Oncol. 2014 Aug;19(4):744-52. doi: 10.1007/s10147-013-0601-2. Epub 2013 Aug 10.
Sarcomas are rare cancers with great variability in clinical and histopathological presentation. The main objective of clinical practice guidelines (CPGs) is to standardize diagnosis and treatment.
From March 2005 to February 2007, all patients diagnosed with localized sarcoma in the Rhône-Alpes region were included in a cohort-based study, to evaluate the compliance of sarcoma management with French guidelines in routine practice and to identify predictive factors for compliance with CGPs.
634 (71 %) patients with localized sarcoma satisfying the inclusion criteria were included out of 891 newly diagnosed sarcomas. Taking into account initial diagnosis until follow-up, overall conformity to CPGs was only 40 % [95 % confidence interval (CI) = 36-44], ranging from 54 % for gastrointestinal stromal tumor to 36 % for soft tissue sarcoma and 42 % for bone sarcoma. In multivariate analysis, primary tumor type [relative risk (RR) = 4.42, 95 % CI = 2.79-6.99, p < 0.001], dedicated multidisciplinary staff before surgery (RR = 4.19, 95 % CI = 2.39-7.35, p < 0.001) and management in specialized hospitals (RR = 3.71, 95 % CI = 2.43-5.66, p < 0.001) were identified as unique independent risk factors for conformity to CPGs for overall treatment sequence.
With only 40 % of total conformity to CPGs, the conclusions support the improvement of initial sarcoma management and its performance in specialized centres or within specialized dedicated networks.
肉瘤是一种罕见癌症,临床和组织病理学表现差异很大。临床实践指南(CPG)的主要目标是规范诊断和治疗。
2005年3月至2007年2月,罗纳-阿尔卑斯地区所有诊断为局限性肉瘤的患者被纳入一项基于队列的研究,以评估肉瘤治疗在常规实践中与法国指南的符合情况,并确定符合CPG的预测因素。
在891例新诊断的肉瘤中,634例(71%)符合纳入标准的局限性肉瘤患者被纳入研究。考虑从初始诊断到随访的情况,总体符合CPG的比例仅为40%[95%置信区间(CI)=36-44],从胃肠道间质瘤的54%到软组织肉瘤的36%以及骨肉瘤的42%不等。在多变量分析中,原发性肿瘤类型[相对风险(RR)=4.42,95%CI=2.79-6.99,p<0.001]、术前有专门的多学科团队(RR=4.19,95%CI=2.39-7.35,p<0.001)以及在专科医院接受治疗(RR=3.71,95%CI=2.43-5.66,p<0.001)被确定为总体治疗序列符合CPG的唯一独立风险因素。
总体符合CPG的比例仅为40%,这些结论支持改善肉瘤的初始治疗及其在专业中心或专业专门网络中的实施情况。